SCHEDULE 13D/AFiled Nov 9, 7:00 PM ET

LENZ Therapeutics, Inc. SCHEDULE 13D/A

Versant Venture Capital VI, L.P.

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.